Pfizer Weighs Sale of Hospital Drugs Unit Amid Activist Pressure

Pfizer Exploring Sale:
Pfizer is considering the sale of its hospital drugs unit, known as Pfizer Hospital, which was formed after the acquisition of Hospira for approximately $17 billion in 201514.

Goldman Sachs Involvement:
The pharmaceutical giant has hired Goldman Sachs to gauge initial interest from potential buyers, including private equity firms and other pharmaceutical companies12.

Activist Investor Pressure:
The move comes under pressure from activist investor Starboard Value, which is pushing Pfizer to divest non-core assets13.

Uncertainty:
The sale is not yet certain, and Pfizer may ultimately decide to retain the unit2.

Strategic Evaluation:
This move indicates Pfizer's strategic evaluation of its business segments, aiming to optimize its portfolio23.

Sources:

1. https://markets.businessinsider.com/news/stocks/pfizer-exploring-sale-of-hospital-drugs-unit-reuters-reports-1034001361

2. https://www.gurufocus.com/news/2597229/pfizer-explores-sale-of-its-hospital-medicines-unit

3. https://endpts.com/pfizer-looking-to-sell-hospital-drugs-unit-reports/

4. https://www.cnbc.com/2024/11/12/pfizer-reportedly-explores-sale-of-hospital-drugs-unit.html